A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
Clinical trial NCT03841448 · TERMINATED
Trial details
- NCT number
- NCT03841448
- Sponsor
- Alnylam Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2022-03-17
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.